Menu
Back to User profile » Dr Yang Xiang
Papers published by Dr Yang Xiang:
Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration
chen L, Huang Y, Dong B, Gu Y, Li Y, Cang W, Sun P, Xiang Y
Journal of Inflammation Research 2022, 15:5889-5904
Published Date: 19 October 2022
Emerging Targets of Immunotherapy in Gynecologic Cancer
Cheng H, Zong L, Kong Y, Gu Y, Yang J, Xiang Y
OncoTargets and Therapy 2020, 13:11869-11882
Published Date: 18 November 2020
Cervical cancer in women aged 25 years or younger: a retrospective study
Kong Y, Zong L, Yang J, Wu M, Xiang Y
Cancer Management and Research 2019, 11:2051-2058
Published Date: 6 March 2019
Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome
Guo P, Liu PF, Yang JJ, Ren T, Xiang Y
Cancer Management and Research 2018, 10:3955-3961
Published Date: 26 September 2018
Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study
Zong LJ, Yang JJ, Wang XY, Kong YJ, Ren T, Zhao J, Feng FZ, Wan XR, Xiang Y
Cancer Management and Research 2018, 10:557-563
Published Date: 23 March 2018
Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China
Wang D, Xiang Y, Wu M, Shen K, Yang J, Huang H, Ren T
OncoTargets and Therapy 2018, 11:1315-1322
Published Date: 7 March 2018
Clinical analysis of 13 males with primary choriocarcinoma and review of the literature
Jiang F, Xiang Y, Feng FZ, Ren T, Cui ZM, Wan XR
OncoTargets and Therapy 2014, 7:1135-1141
Published Date: 20 June 2014
Endometrial carcinoma with yolk sac tumor-like differentiation and elevated serum ß-hCG: a case report and literature review
Ji M, Lu Y, Guo L, Feng F, Wan X, Xiang Y
OncoTargets and Therapy 2013, 6:1515-1522
Published Date: 24 October 2013